Key result
CNS involvement at diagnosis is not linked to overall survival in Asian variant intravascular large B-cell lymphoma.
Why the study?
There are limited data about the influence of CNS involvement on prognosis in patients with the Asian variant of intravascular large B-cell lymphoma.
Does CNS involvement affect overall survival in patients with the Asian variant of intravascular large B-cell lymphoma treated with R-CHOP?
Cohort (n=46)
No
Does CNS involvement affect overall survival in patients with the Asian variant of intravascular large B-cell lymphoma treated with R-CHOP?
CNS involvement does not appear to significantly alter overall survival in patients with the Asian variant of IVLBCL treated with R-CHOP, though overall outcomes remain unsatisfactory.
Answers are grounded in this paper and cite their sources.
Does not support CNS-directed intensification at diagnosis; leaves open optimal risk stratification in Asian-variant IVLBCL.
BACKGROUND/AIMS: There are limited data about the influence of the central nervous system (CNS) involvement on the prognosis for patients with the Asian variant of intravascular large B-cell lymphoma (IVLBCL). METHODS: We analyzed 46 patients who were diagnosed with IVLBCL between 2001 and 2018. All patients were treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). RESULTS: CNS involvement was diagnosed by cerebrospinal fluid analysis (n = 6) and brain imaging (n = 5) in 11 patients at diagnosis, and four cases with CNS relapse were found. Thus, 15 patients had CNS involvement (15/46, 33%). The clinical characteristics were not different between patients with and without CNS involvement, but all patients with CNS involvement belonged to the high-risk group of CNS-International Prognostic Index (IPI). Thirty-one patients achieved a complete response (67%, 31/46) whereas eight patients showed disease progression and six patients died after the first or second cycle of R-CHOP. CNS-directed therapy such as high-dose methotrexate was combined with R-CHOP for patients with CNS involvement, and five patients were alive without relapse. The median overall survival of all patients was 45.0 months, and overall survival was not different according to the involvement of CNS. CONCLUSION: The treatment outcome of patients with the Asian variant of IVLBCL is still not satisfactory. The prediction of CNS involvement based on the clinical features including CNS-IPI score might not serve to identify patients at high risk of CNS involvement, either. Thus, more effective strategies for diagnosis and treatment should be developed.
No takes yet. Share an insight, caveat, or question.
Yoon et al. (2019) conducted a cohort in Asian variant of intravascular large B-cell lymphoma (n=46). Central nervous system involvement vs. No central nervous system involvement was evaluated on Overall survival (HR 0.508, 95% CI 0.131-1.980, p=0.329). Central nervous system involvement at diagnosis was not associated with overall survival in patients with the Asian variant of intravascular large B-cell lymphoma.
Synapse has enriched 10 related papers. Consider them for comparative context: